arrow - cilazapril 1
actavis new zealand limited - cilazapril monohydrate 1.043mg equivalent to 1.0 mg cilazpril - film coated tablet - 1 mg - active: cilazapril monohydrate 1.043mg equivalent to 1.0 mg cilazpril excipient: hypromellose lactose monohydrate maize starch opadry yellow 85f12471 purified talc sodium stearyl fumarate - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.
arrow - cilazapril 2.5
actavis new zealand limited - cilazapril monohydrate 2.608mg equivalent to 2.5 mg cilazapril - film coated tablet - 2.5 mg - active: cilazapril monohydrate 2.608mg equivalent to 2.5 mg cilazapril excipient: hypromellose lactose monohydrate maize starch opadry brown 85f16870 purified talc sodium stearyl fumarate - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.
arrow - cilazapril 5
actavis new zealand limited - cilazapril monohydrate 5.216mg equivalent to 5.0 mg cilazapril - film coated tablet - 5 mg - active: cilazapril monohydrate 5.216mg equivalent to 5.0 mg cilazapril excipient: hypromellose lactose monohydrate maize starch opadry brown 85f16910 purified talc sodium stearyl fumarate - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.
arrow - ipratropium 250
actavis new zealand limited - ipratropium bromide monohydrate 0.0261%{relative} equivalent to ipratropium 0.025% w/v - solution for inhalation - 250 mcg/ml - active: ipratropium bromide monohydrate 0.0261%{relative} equivalent to ipratropium 0.025% w/v excipient: hydrochloric acid sodium chloride water for injection - ipratropium bromide is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema and when used concomitantly with inhaled beta-agonists, for asthma.
arrow - ipratropium 500
actavis new zealand limited - ipratropium bromide monohydrate 0.0261%{relative} equivalent to ipratropium 0.025% w/v - solution for inhalation - 0.5 mg/2ml - active: ipratropium bromide monohydrate 0.0261%{relative} equivalent to ipratropium 0.025% w/v excipient: hydrochloric acid sodium chloride water for injection - ipratropium bromide is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema and when used concomitantly with inhaled beta-agonists, for asthma.
paracode
actavis new zealand limited - codeine phosphate hemihydrate 8mg equivalent to 5.92 mg codeine; ; paracetamol 500mg - tablet - 500mg/8mg - active: codeine phosphate hemihydrate 8mg equivalent to 5.92 mg codeine paracetamol 500mg excipient: magnesium stearate maize starch povidone starch - indicated for the temporary relief of pain and discomfort associated with: · headache · migraine headache · backache · toothache/dental surgery · menstrual pain · muscular pain · neuralgia · cold and flu symptoms · sore throat · arthritis
paracode
actavis new zealand limited - codeine phosphate hemihydrate 8mg equivalent to 5.92 mg codeine; ; paracetamol 500mg - tablet - 500mg/8mg - active: codeine phosphate hemihydrate 8mg equivalent to 5.92 mg codeine paracetamol 500mg excipient: magnesium stearate maize starch povidone starch
arrow - amlodipine 10
actavis new zealand limited - amlodipine besilate 13.88mg equivalent to amlodipine 10.0 mg - tablet - 10 mg - active: amlodipine besilate 13.88mg equivalent to amlodipine 10.0 mg excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate water
arrow - amlodipine 5
actavis new zealand limited - amlodipine besilate 6.94mg equivalent to amlodipine 5.0 mg - tablet - 5 mg - active: amlodipine besilate 6.94mg equivalent to amlodipine 5.0 mg excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate water
arrow - carvedilol
actavis new zealand limited - carvedilol 12.5mg - tablet - 12.5 mg - active: carvedilol 12.5mg excipient: colloidal silicon dioxide crospovidone iron oxide red iron oxide yellow lactose monohydrate magnesium stearate povidone sucrose